Prostate Cell News Volume 12.45 | Nov 26 2021

    0
    12







    2021-11-26 | PCN 12.45


    Prostate Cell News by STEMCELL Technologies
    Vol. 12.45 – 26 November, 2021
    TOP STORY

    H3K27ac HiChIP in Prostate Cell Lines Identifies Risk Genes for Prostate Cancer Susceptibility

    The authors assessed the utility of chromosome conformation capture coupled with immunoprecipitation (HiChIP) to identify target genes for prostate cancer genome-wide association studies risk loci.
    [American Journal of Human Genetics]

    Abstract
    Virtual Conference Exhibition: Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    Prognostic and Therapeutic Significance of COP9 Signalosome Subunit CSN5 in Prostate Cancer

    Deregulation of CSN5, a putative androgen receptor (AR), could affect diverse cellular functions that contribute to tumor development. Inhibition of CSN5 repressed metabolic pathways, including oxidative phosphorylation and glycolysis in AR-negative prostate cancer cells.
    [Oncogene]

    Abstract

    TMPRSS4 Promotes Cancer Stem–Like Properties in Prostate Cancer Cells through Upregulation of SOX2 by SLUG and TWIST1

    Scientists investigated whether transmembrane serine protease 4 (TMPRSS4) confered cancer stem–like properties to prostate cancer cells and characterized the underlying mechanisms.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    TCF7L1 Regulates Cytokine Response and Neuroendocrine Differentiation of Prostate Cancer

    Researchers identified androgen-deprivation therapy-mediated upregulation of transcription factor 7 like 1 (TCF7L1), which increased the cytokine response and enhanced neuroendocrine differentiation of prostate cancer through interleukin-8/C-X-C motif chemokine receptor type 2 signaling activation.
    [Oncogenesis]

    Full Article

    PCK1 Regulates Neuroendocrine Differentiation in a Positive Feedback Loop of LIF/ZBTB46 Signaling in Castration-Resistant Prostate Cancer

    Investigators identified that PCK1 was a pivotal regulator in therapy-induced neuroendocrine differentiation of prostate cancer through a LIF/ZBTB46-driven glucose metabolism pathway.
    [British Journal of Cancer]

    Abstract

    MYB Interacts with Androgen Receptor, Sustains Its Ligand-Independent Activation and Promotes Castration Resistance in Prostate Cancer

    Scientists investigated MYB-androgen receptor crosstalk and its functional significance. MYB-overexpressing prostate cancer cells exhibited greater tumorigenicity when implanted orthotopically and quickly regained growth following castration leading to shorter mice survival.
    [British Journal of Cancer]

    Abstract

    Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogues for the Treatment of Androgen Receptor-Positive Prostate and Breast Cancers

    Androgen receptor has essential roles in the growth of prostate cancer and some breast cancers. A combination of EPI-7170 with palbociclib attenuated the in vivo growth of human CRPC xenografts that were resistant to antiandrogens.
    [Molecular Cancer therapeutics]

    AbstractFull Article

    Sympathetic Signaling Facilitates Progression of Neuroendocrine Prostate Cancer

    The authors revealed that high concentrations of the sympathetic neurotransmitter norepinephrine induced neuroendocrine differentiation-like changes in prostate cancer cells in vitro, evident by their characteristic cellular and molecular changes.
    [Cell Death Discovery]

    Full Article

    NUAK Family Kinase 2 Is a Novel Therapeutic Target for Prostate Cancer

    Scientists found that NUAK family kinase 2 (NUAK2) expression was elevated in prostate cancer (PC) and metastatic castration resistant PC versus normal tissue, and expression correlated with an increased risk of metastasis.
    [Molecular Carcinogenesis]

    Abstract

    Imatinib Mesylate Inhibits Androgen-Independent PC-3 Cell Viability, Proliferation, Migration, and Tumor Growth by Targeting Platelet-Derived Growth Factor Receptor-α

    Researchers examined the role of platelet-derived growth factor receptors (PDGFRs) in androgen-independent PC-3 cells and found that PDGFRα was upregulated in androgen-independent PC-3 cells compared with normal prostate epithelial cells.
    [Life Sciences]

    Abstract
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSRâ„¢ Plus.
    REVIEWS

    Extracellular Vesicles as a Source of Prostate Cancer Biomarkers in Liquid Biopsies: A Decade of Research

    Prostate cancer is a global cancer burden and considerable effort has been made through the years to identify biomarkers for the disease. Investigators present the knowledge acquired during the last decade that constitutes a solid basis for the future development of liquid biopsy tests for prostate cancer.
    [British Journal of Cancer]

    Full Article

    Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Cochrane Network Meta-Analysis

    Scientists assess the comparative effectiveness and ranking of minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia.
    [BJU International]

    Abstract

    Non-Invasive Urine Metabolomics of Prostate Cancer and Its Therapeutic Approaches: A Current Scenario and Future Perspective

    The authors provide a concise overview of the prostate cancer metabolomics-based potential discriminating molecules in urine samples using nuclear magnetic resonance spectroscopy and mass spectrometry.
    [Expert Review of Proteomics]

    Abstract
    INDUSTRY AND POLICY NEWS

    CPRIT Awards $24 Million to Three North Texas Universities to Recruit Cancer Researchers

    Texas’ cancer-fighting agency is awarding $24 million to three Dallas-Fort Worth universities for the recruitment of established and emerging researchers.
    [The Dallas Morning News]

    Press Release
    FEATURED EVENT

    ESMO Immuno-Oncology Congress

    December 8 – 11, 2021
    Geneva, Switzerland

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Molecular and Cellular Mechanisms

    University of Washington – Seattle, Washington, United States

    Tenure Track Assistant Professor – Mechanistic Aspects of Prostate Cancer

    The University of Chicago – Chicago, Illinois, United States

    Tenure Track Faculty Position – Cancer Research

    University of Maryland School of Medicine – Baltimore, Maryland, United States

    Postdoctoral Position – Epigenetic Reprogramming

    University of Freiburg – Freiburg, Germany

    Postdoctoral Fellowship – Cancer and Infections

    Lund University РMalm̦, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter